SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

pharmacology chemotherapy

» Start this Course
(Practice similar questions for free)
Question:

Isoniazid mechanism

Author: Suzuki



Answer:

Isoniazid (INH) is a structural congener of pyridoxine. Its mechanism of action involves inhibition of the synthesis of mycolic acids, essential parts of mycobacterial cell walls. It is a prodrug that is activated by a mycobacterial catalase-peroxidase (KatG). It inhibits enoyl acyl carrier protein reductase (InhA) and a β-ketoacyl-ACP synthase (KasA) within the unique Type II fatty acid synthase system for mycolic acids. INH is bactericidal for actively growing tubercle bacilli, but is less effective against dormant organisms.


0 / 5  (0 ratings)

1 answer(s) in total

Author

Suzuki
Suzuki